Breaking News, Collaborations & Alliances

Tiziana Life Sciences & Renaissance Partner on Nasal Foralumab Production

Aim to optimize the current formulation of intranasal foralumab and develop a comprehensive plan for its scalable production in a nasal device.

Author Image

By: Charlie Sternberg

Associate Editor

Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a collaborative agreement with Renaissance Lakewood LLC, a Contract Development and Manufacturing Organization (CDMO) specializing in nasal drug delivery. This partnership aims to optimize the current formulation of intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, and develop a comprehensive plan for its scalable production in a nasal device. Intranasal foralumab ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters